133 related articles for article (PubMed ID: 27362259)
1. Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment.
Li D; Shi J; Du Y; Chen K; Liu Z; Li B; Li J; Tao F; Gu H; Jiang C; Fang J
PLoS One; 2016; 11(6):e0158214. PubMed ID: 27362259
[TBL] [Abstract][Full Text] [Related]
2. Tumor resistance to anti-VEGF therapy through up-regulation of VEGF-C expression.
Li D; Xie K; Ding G; Li J; Chen K; Li H; Qian J; Jiang C; Fang J
Cancer Lett; 2014 Apr; 346(1):45-52. PubMed ID: 24333721
[TBL] [Abstract][Full Text] [Related]
3. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
4. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
[TBL] [Abstract][Full Text] [Related]
5. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance.
Pyaskovskaya ON; Dasyukevich OI; Kolesnik DL; Garmanchouk LV; Todor IN; Solyanik GI
Exp Oncol; 2007 Sep; 29(3):197-202. PubMed ID: 18004244
[TBL] [Abstract][Full Text] [Related]
6. Tumor-mast cell interactions: induction of pro-tumorigenic genes and anti-tumorigenic 4-1BB in MCs in response to Lewis Lung Carcinoma.
Wensman H; Kamgari N; Johansson A; Grujic M; Calounova G; Lundequist A; Rönnberg E; Pejler G
Mol Immunol; 2012 Apr; 50(4):210-9. PubMed ID: 22343053
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.
Nordström L; Andersson E; Kuci V; Gustavsson E; Holm K; Ringnér M; Guldberg P; Ek S
BMC Cancer; 2015 Apr; 15():273. PubMed ID: 25880212
[TBL] [Abstract][Full Text] [Related]
8. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic Therapy Induces Hepatic Tumor Vascular Network Rearrangement to Receive Perfusion via the Portal Vein and Hepatic Artery.
Kang W; Lim JS; Park MS; Koh GY; Kim H
J Vasc Res; 2016; 53(1-2):72-82. PubMed ID: 27643516
[TBL] [Abstract][Full Text] [Related]
10. Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth.
Cha TL; Chuang MJ; Tang SH; Wu ST; Sun KH; Chen TT; Sun GH; Chang SY; Yu CP; Ho JY; Liu SY; Huang SM; Yu DS
Mol Carcinog; 2015 Mar; 54(3):167-77. PubMed ID: 24115089
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor activities of TZT-1027 against TNF-alpha or IL-6 secreting Lewis lung carcinoma in vivo.
Natsume T; Koh Y; Kobayashi M; Fukumoto H; Takahashi F; Nakamura T; Ohe Y; Saijo N; Nishio K
Cancer Chemother Pharmacol; 2002 Jan; 49(1):35-47. PubMed ID: 11855751
[TBL] [Abstract][Full Text] [Related]
12. A transcriptomic computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting tumor cell growth and survival.
Moulos P; Papadodima O; Chatziioannou A; Loutrari H; Roussos C; Kolisis FN
BMC Med Genomics; 2009 Dec; 2():68. PubMed ID: 20003503
[TBL] [Abstract][Full Text] [Related]
13. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
14. Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
Raynal NJ; Lee JT; Wang Y; Beaudry A; Madireddi P; Garriga J; Malouf GG; Dumont S; Dettman EJ; Gharibyan V; Ahmed S; Chung W; Childers WE; Abou-Gharbia M; Henry RA; Andrews AJ; Jelinek J; Cui Y; Baylin SB; Gill DL; Issa JP
Cancer Res; 2016 Mar; 76(6):1494-505. PubMed ID: 26719529
[TBL] [Abstract][Full Text] [Related]
15. Identification of epigenetically silenced genes in tumor endothelial cells.
Hellebrekers DM; Melotte V; Viré E; Langenkamp E; Molema G; Fuks F; Herman JG; Van Criekinge W; Griffioen AW; van Engeland M
Cancer Res; 2007 May; 67(9):4138-48. PubMed ID: 17483324
[TBL] [Abstract][Full Text] [Related]
16. Heparanase expression is associated with histone modifications in glioblastoma.
Hong X; Nelson K; Lemke N; Kalkanis SN
Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963
[TBL] [Abstract][Full Text] [Related]
17. Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo.
Tang SJ; Ho MY; Cho HC; Lin YC; Sun GH; Chi KH; Wang YS; Jhou RS; Yang W; Sun KH
Int J Cancer; 2008 Dec; 123(12):2840-8. PubMed ID: 18814280
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
Teodoridis JM; Strathdee G; Brown R
Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
[TBL] [Abstract][Full Text] [Related]
19. Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice.
Huh JE; Baek YH; Lee MH; Choi DY; Park DS; Lee JD
Cancer Lett; 2010 Jun; 292(1):98-110. PubMed ID: 20188461
[TBL] [Abstract][Full Text] [Related]
20. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells.
El-Khoury V; Gomez D; Liautaud-Roger F; Trussardi-Régnier A; Dufer J
Cytometry A; 2004 Dec; 62(2):109-17. PubMed ID: 15517561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
